Catalyst Wire Dossier Catalyst Wire Dossier

ENOBY

DENOSUMAB-QBDE · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ENOBY, covering 2025-09-26 to 2025-10-29. Get the full timeline:

Most recent: FDA Approved: ENOBY — Original Application (Hikma Pharmaceuticals USA Inc.)

See pricing